India's pharma stocks log best week since March 2025 on strong earnings, April sales

Cipla

08/05/2026 11:06

** India's pharma index .NIPHARM rises 3.6% this week, logs best weekly performance since March 2025

** Gains led by strong quarterly results from key constituents such as Laurus Labs LAUL.NS, Ajanta Pharma AJPH.NS, Lupin LUPN.NS and data showing double-digit growth in industry in April

** LAUL up 11.6%, AJPH up 7.5%

** Data released earlier this week by Pharmarack shows that pharma industry sustained double-digit growth at 10.3% year-on-year in April, supported by new launches and volume growth

** Sun Pharmaceuticals SUN.NS, Dr Reddy's REDY.NS, Cipla CIPL.NS and Lupin LUPN.NS clock sales growth of 15.1%, 13.9%, 13.8% and 12.5%, respectively, in April - Pharmarack

** Part of the growth in April is also driven by contribution from weight loss drugs launched in the recent past, says Nomura

** NIPHARM up 6% this year, outperforming the 7.5% drop in benchmark Nifty 50 index .NSEI

 (Reporting by Bharath Rajeswaran in Bengaluru)

 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))